Acme United Q1 Sales Up 14% to $52.3M, Earnings Down 40%
Net sales rose 14% to $52.3 million in Q1 on My Medic acquisition and 6% organic growth. Net income fell 40% to $1.0 million due to higher tariffs, quality assurance expenses and rising healthcare costs.
1. Q1 Financial Results
Acme United recorded net sales of $52.3 million for the quarter ended March 31, 2026, up 14% from $46.0 million a year earlier. Net income declined 40% to $1.0 million, or $0.24 per diluted share, from $1.7 million, reflecting elevated costs.
2. Margin and Expense Drivers
Gross margin improved slightly to 39.7% from 39.0%, but higher cost of sales and operating expenses pressed earnings. Tariff-related costs, enhanced quality assurance spending at the Med-Nap facility and rising employee healthcare expenses contributed to the decline.
3. My Medic Acquisition
The January 15 acquisition of My Medic assets, which generates annual sales of $19 million, contributed to the 14% sales increase while having minimal impact on first-quarter earnings. Seasonal demand suggests majority of My Medic profitability will materialize in the fourth quarter.
4. Operational Initiatives
The company invested in a new Spill Magic facility in Tennessee, automation upgrades and site consolidation in Canada to lower future costs and expand capacity. It also added $10 million of inventory purchases for delivery in coming quarters to mitigate supply risks from the Iran conflict.